in Supplementary Table S2 .
Immunostaining. After fixation with 4% paraformaldehyde, paraffin-embedded coronal sections through the hypothalamus were processed for immunoreactivity using standard immunofluorescence procedures. Sections were incubated overnight at 4°C with mouse anti-GFAP (1:500; Sigma-Aldrich) or rabbit anti-Iba-1 (1:500; Wako Pure Chemicals). Immunofluorescence was performed with a combination of Alexa
Fluor 488-or Alexa Fluor 594-labeled anti-rabbit or anti-mouse secondary antibodies and Hoechst 33258, which was used to identify cell nuclei. Images were captured on a microscope equipped with a color digital camera (Nikon, Japan). For Iba-1 and GFAP immunostaining in which discrete cells could be identified, cells were manually counted on 3 slides per rat, and replicate values from each rat were individually averaged before determining group means (6 rats per group). 
UA determination in

Immunofluorescence for primary cultured cells. Primary hypothalamic neurons
and glial cells were stained as described. In brief, the cells were fixed with 4% paraformaldehyde for 5 min, followed by penetration with Triton-X 100 (Invitrogen).
After blocking with 5% BSA (Sigma), the cells were incubated with primary antibodies to NeuN (1:100, Millipore), GFAP (1:500, Sigma-Aldrich), Iba- DMEM/F12 (v/v 1:1) supplemented with 10% FBS (GIBCO) and 2 mM glutamine at 37°C in a 5% CO 2 atmosphere and were passaged 2-3 times before use.
Western blotting analysis. Western blotting analysis was performed according to standard methods. Briefly, lysate protein concentrations were equalized, resolved on sodium dodecyl sulfate polyacrylamide gel electrophoresis gels, and transferred to nitrocellulose membranes. The gels were run under the same experimental conditions.
Proteins were detected with the appropriate primary and secondary antibodies, and protein bands were visualized using an enhanced chemiluminescence kit (Merck Millipore, Billerica, MA, USA). Data typical of 3 independent experiments are shown.
Brain MRI in rats. Wistar rats (6 weeks old) were fed standard laboratory chow or a HUAD for 3 months. High-resolution MRI acquisitions were performed on a 7T
Avance 600 MHz/89 mm wide-bore vertical MR spectrometer (Bruker BioSpin, Billerica, MA) using a 25 mm inner diameter 1 H birdcage coil. The 7T MRI system was equipped with actively shielded gradient coils (maximum gradient strength of 100 G/cm) and a Paravision (version 5.1) console interface.
All rats underwent isoflurane anesthesia in an induction chamber. The rats were placed on a bite bar, and their heads were placed into a radiofrequency coil and secured to a cradle created specifically for the MRI system. The coil was then inserted vertically into a scanner heated to maintain thermoneutrality (32°C). The coil was 13 / 17 equipped with an adjustable anesthetic flow and vacuum system to maintain sedation throughout the experiment. Total scan time was 1-1.5 h, during which anesthesia was titrated to ensure appropriate sedation. Following the imaging paradigm (described in Supplementary Tab. S3) , mice were removed from the coil and allowed to recover in their home cage 3, 4 . 
Supplementary Discussion
Here we report that rats with systemic hyperuricemia exhibited hypothalamic inflammation, which is a manifestation of neuronal injury that in turn triggers gliosis that involves both microglial and astroglial cell populations. We found that UA in serum can pass through the BBB and induce potent inflammation as well as gliosis in the hypothalamus. Hypothalamic NF-κB activation mainly occurred in neurons, and NF-κB inhibition was able to protect against UA-induced hypothalamic inflammation in the mice. Importantly, MRI showed that hypothalamic gliosis was closely associated with hyperuricemia in rodents and humans, raising the possibility of a common mechanism of UA-induced hypothalamic inflammation across species.
Finally, rats fed a HUAD exhibited dyslipidemia and glucose intolerance, which is likely mediated by hypothalamic inflammation and neuroendocrine alterations.
In addition to its role as an inflammatory regulator, NF-κB signaling also controls cell survival, apoptosis and synaptic plasticity 5 . More specifically, during nervous system development, NF-κB is activated in growing neurons by neurotrophic factors and induces the expression of genes involved in cell differentiation and survival 6 .
NF-κB can also induce the differentiation of neuronal stem cells into astrocytes depending on the signaling cascade 7 and can prevent the death of neurons by inducing the production of antiapoptotic proteins in acute neurodegenerative conditions 8, 9 . The involvement of NF-κB signaling in dendritogenesis, dendritic arborization and axonal growth 10 has been well documented, as has its mediation of myelination in Schwann cells 11 .
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A metabolic disorder phenotype can be induced by hypothalamic dysfunction; however, how hypothalamic dysfunction controls peripheral metabolic organs is still uncertain. Indeed, we revealed a direct link between UA and neuropeptides as well as neuroendocrine factors, indicating that UA suppresses the expression of Pomc, Crh, Trh, Ghrh, and Gnrh. The importance of Pomc, Trh, and Crh in the regulation of thermogenesis and glucose consumption in BAT and skeletal muscle has been well established 12 . Hypothalamic immunity mediated by IKKβ/NF-κB can inhibit neuroendocrine factors, such as gonadotropin-releasing hormone 12 . Based on these findings, we propose that UA causes hypothalamic inflammation and NF-κB activation, at least in part, in POMC and AgRP neurons, which directly influences feeding and glucose homeostasis through the autonomic nervous system. On the other hand, the neurons that release neurotransmitter may have direct synaptic connections with the neurons that release hypothalamic regulatory peptides 13 . Although the present study did not explore the mechanisms that effectively deliver the neural signal to the affected peripheral organs, it is tempting to propose that both the autonomic nervous system and hormones could be involved.
